<DOC>
	<DOCNO>NCT02704052</DOCNO>
	<brief_summary>Venous thromboembolism ( VTE ) encompass deep venous thrombosis pulmonary embolus , proximate cause death 100,000 hospitalized patient per year . To put good context , VTE kill people year annual morbidity motor vehicle crash breast cancer combine . Surgeons commonly provide enoxaparin , low molecular weight heparin , VTE prophylaxis . Enoxaparin 's activity quantify anti-Factor Xa ( aFXa ) level . Studies enoxaparin metabolism patient traumatic injury , thermal injury , undergo reconstructive surgery show standard dose result inadequate aFXa level , likely hypermetabolic state associate significant injury . Small study associate subtherapeutic aFXa level increase risk life limb-threatening VTE event . Prior work show 2-10 % high risk surgical patient VTE event despite enoxaparin prophylaxis . The investigator believe surgical patient would benefit individualized dose regimen enoxaparin prophylaxis individualized dosing decrease observe rate life limb-threatening post-operative VTE event . This project critically examine pharmacokinetics prophylactic dos enoxaparin surgical patient , evaluate alteration enoxaparin dose magnitude frequency affect peak trough aFXa level well risk re-operative hematoma . If subtherapeutic aFXa level observe , study design , implement test clinical protocol optimize post-operative aFXa level . Although explicit Aim , study also provide important preliminary data VTE rate surgical patient range range aFXa level .</brief_summary>
	<brief_title>Real-time Anti-Factor Xa Measurements Surgical Patients Examine Enoxaparin Metabolism Optimize Enoxaparin Dose</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>Adults , ( age≥18 ) Patients surgery general anesthesia . Postoperative stay ≥2 day Contradiction use enoxaparin History intracranial bleeding/stroke , hematoma bleed disorder , heparininduced thrombocytopenia positive , heparininduced thrombocytopenia positive Creatinine clearance ≤ 30mL/min Serum creatinine &gt; 1.6mg/dL Epidural anesthesia Patients place nonenoxaparin chemoprophylaxis regimen per surgeon 's discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>